Melatonin Oral Gel for Oral Mucositis in Patients With Head and Neck Cancer Undergoing Chemoradiation

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

84

Participants

Timeline

Start Date

November 30, 2015

Primary Completion Date

December 31, 2017

Study Completion Date

December 22, 2017

Conditions
Oral Mucositis
Interventions
DRUG

Melatonin oral gel 3%

DRUG

Placebo oral gel

Trial Locations (11)

15706

Hospital Clínico Universitario de Santiago, Santiago de Compostela

17007

Institut Català d'Oncologia Girona, Girona

28040

Hospital San Carlos, Madrid, Madrid

28046

Hospital Universitario La Paz, Madrid

29010

Hospital Universitario Virgen de la Victoria, Málaga

39008

Hospital Universitario Marqués de Valdecilla, Santander

50009

Hospital Miguel Servet, Zaragoza

08916

Institut Català d'Oncologia ICO Badalona, Badalona

08907

Institut Català d'Oncologia L'Hospitalet, L'Hospitalet de Llobregat

08026

Hospital de la Santa Creu i Sant Pau, Barcelona

08035

Hospital Universitari de la Vall d'Hebron, Barcelona

Sponsors

Lead Sponsor

All Listed Sponsors
collaborator

Institut Català d'Oncologia L'Hospitalet

UNKNOWN

collaborator

Hospital Universitari de la Vall de Hebron

UNKNOWN

collaborator

Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau

OTHER

collaborator

Institut Català d'Oncologia ICO Girona

UNKNOWN

collaborator

Institut Català d'Oncologia ICO Badalona

UNKNOWN

collaborator

Hospital Miguel Servet

OTHER

collaborator

Hospital Universitario La Paz

OTHER

collaborator

Hospital Universitario Marqués de Valdecilla

OTHER

collaborator

Hospital Universitario Virgen de la Victoria

OTHER

collaborator

Hospital San Carlos, Madrid

OTHER

collaborator

Hospital Clinico Universitario de Santiago

OTHER

lead

Spherium Biomed

INDUSTRY